MARKET TALK: AstraZeneca Crestor Victory Removes Uncertainty

30th Jun 2010 07:56

0656 GMT [Dow Jones] AstraZeneca's (AZN.LN) Crestor patent victory has lifted a significant uncertainty says Shore Capital. Says while there may be little scope to upgrade consensus forecasts, thinks this removes a significant overhang from the AstraZeneca investment case. Thinks investors will now focus more on the potential of the emerging markets opportunity and that, combined with the removal of this near-term uncertainty, should provide a catalyst for a re-rating of the shares. Keeps at buy. Shares closed Tuesday at 2947p. ([email protected]) Contact us in London. +44-20-7842-9464 [email protected] (END) Dow Jones Newswires June 30, 2010 02:56 ET (06:56 GMT)